Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Immunovant, Inc. (IMVT)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Dec-31-22Jun-30-22Mar-31-22Dec-31-21Sep-30-21Jun-30-21Mar-31-21
   10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K
Cash flows from operating activities          
Net loss    -197.1-187.2-168.2-158.6-111.2-107.4
   
Adjustments to reconcile net loss to net cash used in operating activities:          
    Stock-based compensation    41.938.131.727.618.718.8
    Depreciation on property and equipment    0.20.20.10.10.10.1
    Non-cash lease expense    1.41.41.31.31.2 
    Changes in operating assets and liabilities:          
        Accounts receivable    -20.5-19.8-8.7 -0.8-0.6
        Prepaid expenses and other current assets    0.913.37.15.44.40.8
        Accounts payable    -1.216.92.4-1.0-4.91.3
        Accrued expenses    3.910.619.218.96.24.5
            Net cash used in operating activities    -171.9-127.3-116.9-107.8-90.7-83.3
   
Cash flows from investing activities          
Purchase of property and equipment    -0.3-0.3-0.2-0.2-0.2-0.2
    Net cash used in investing activities    -0.3-0.3-0.2-0.2-0.2-0.2
   
Cash flows from financing activities          
Proceeds from stock options exercised    0.0     
    Net cash provided by financing activities    200.2  201.4189.7383.1

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy